Blair William & CO Blueprint Medicines Corp Transaction History
Blair William & CO
- $32 Billion
- Q2 2024
A detailed history of Blair William & CO transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Blair William & CO holds 6,047 shares of BPMC stock, worth $532,559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,047
Previous 6,616
8.6%
Holding current value
$532,559
Previous $627,000
3.83%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$585 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$576 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$517 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$285 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$217 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.26B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...